🔥Finally published🔥
IDSA Guidelines on the Treatment and Management of Complicated Urinary Tract Infections (cUTI)
Thanks @Inox94#idxposts
https://t.co/R0nsUyfzWF
#IDtwitter#IDXpost this is something I have been worried for a while. My micro lab does not usually test for ertapenem R and most extrapolate susceptibility from meropenem and prefer to use Erta for OPAT because is more convenient @BradSpellberg@DrToddLee@ABsteward@wwrighID
Evaluation of methicillin-resistant Staphylococcus aureus nasal swab screening at a large comprehensive cancer center: In patients with cancer, MRSA swab culture screening results had consistently high NPV and sensitivity regardless of culture site. https://t.co/GW1RcmqiwA
It's the mooooost, wonderful tiiiiiiime of the yeeeeear! 🎶🦠
Love the "Notable Updates from the 2023 guidance document" section!
https://t.co/T6jpVt07HK
【Refractory VRE infections】@TXMedCenter Citywide Conference
👉Great discussion by @AmpC_Stabler@MDAndersonNews regarding daptomycin/linezolid-resistant VRE infections!
👉Oritavancin might be considered
👉Orita+beta-lactam synergy (in-vitro) has been reported